Stocktoria
ANAVEX LIFE SCIENCES CORP. AVXL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2006-04-13
ANAVEX LIFE SCIENCES CORP. statistics & valuation
Market cap$242.8M
P / B2.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -44.7% | -31.7% | -30.8% | -31.4% | -23.5% |
| Return on equity | -48.9% | -35.8% | -33.5% | -33.7% | -25.1% |
Source: SEC EDGAR filings · CIK 0001314052 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.